These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33909795)

  • 1. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
    Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
    Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
    Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
    World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
    Ogutmen Koc D; Bektas S
    Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
    Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
    Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
    Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
    Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
    Wang X; Zhang Q; Han F; Wu Y
    Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Wu M; Feng S; Qian M; Wang S; Zhang K
    Risk Manag Healthc Policy; 2022; 15():2243-2255. PubMed ID: 36475275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
    Na YS; Kim SG; Cho SJ
    Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
    Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
    World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.
    Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
    Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
    World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer.
    Tsai YC; Hsiao WH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS
    Aliment Pharmacol Ther; 2013 May; 37(10):969-78. PubMed ID: 23550594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population.
    Cai HL; Tong YL
    World J Clin Cases; 2021 Nov; 9(31):9431-9439. PubMed ID: 34877278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.
    Salazar BE; Pérez-Cala T; Gomez-Villegas SI; Cardona-Zapata L; Pazos-Bastidas S; Cardona-Estepa A; Vélez-Gómez DE; Justinico-Castro JA; Bernal-Cobo A; Dávila-Giraldo HA; Benítez-Guerra JC; Valencia-Cárdenas JT; Ospina EJ; Castaño-Llano R; Bravo MM; Cataño-Correa JC; Zabaleta J; Trespalacios-Rangel AA; Cock-Botero AM; Roldán-Pérez MI; Martínez A
    Virchows Arch; 2022 Apr; 480(4):759-769. PubMed ID: 35089403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
    Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
    Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
    Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
    Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
    Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
    Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
    Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIAGNOSTIC ACCURACY OF GASTROPANEL® FOR ATROPHIC GASTRITIS IN BRAZILIAN SUBJECTS AND THE EFFECT OF PROTON PUMP INHIBITORS.
    Mattar R; Marques SB; Ribeiro IB; Visconti TAC; Funari M; DE Moura EGH
    Arq Gastroenterol; 2020; 57(2):154-160. PubMed ID: 32609157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.